Selective inhibition of heme oxygenase, without inhibition of nitric oxide synthase or soluble guanylyl cyclase, by metalloporphyrins at low concentrations

Drug Metabolism and Disposition

Volumn 27, Issue 10, 1999, Pages 1214-1219

  Appleton, Scott D ^a   Chretien, Marc L ^a   Mclaughlin, Brian E ^a   Vreman, Hendrik J ^b   Stevenson, David K ^b   Brien, James F ^a   Nakatsu, Kanji ^a   Maurice, Donald H ^a   Marks, Gerald S ^a  

^a QUEEN S UNIVERSITY   (Canada)

^b STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

GUANYLATE CYCLASE; HEME OXYGENASE; METALLOPORPHYRIN; N ACETYL S NITROSOPENICILLAMINE; NITRIC OXIDE SYNTHASE; POLACRILIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BRAIN MICROSOME; CONTROLLED STUDY; CYTOSOL; DRUG EFFECT; DRUG POTENCY; ENZYME ACTIVITY; ENZYME INHIBITION; ENZYME SPECIFICITY; LONG TERM POTENTIATION; MEMBRANE DEPOLARIZATION; NONHUMAN; PRIORITY JOURNAL; RAT; SAMPLING;

ANIMALS; BRAIN; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME INHIBITORS; GUANYLATE CYCLASE; HEME OXYGENASE (DECYCLIZING); LUNG; MALE; METALLOPORPHYRINS; NITRIC OXIDE SYNTHASE; RATS; RATS, SPRAGUE-DAWLEY;

EID: 0032876719     PISSN: 00909556     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. Bredt DS and Snyder SH (1990) Nitric oxide, a novel neuronal messenger. Neuron 8:3-11.
2. Brien JF, Reynolds JD, Cunningham MP, Parr AM, Woddock S and Kalisch BE (1995) Nitric oxide synthase activity in the hippocampus, frontal cortex, and cerebellum of the guinea pig: Ontogeny and in vitro ethanol exposure. Alcohol 12:327-333.
3. Chernick RJ, Martasek P, Levere RD, Margreiter R and Abraham NG (1989) Sensitivity of human tissue heme oxygenase to a new synthetic metalloporphyrin. Hepatology 10:365-369.
4. Cook MN, Marks GS, Vreman HJ, Nakatsu K, Stevenson DK and Brien JF (1996) Ontogeny of heme oxygenase activity in the hippocampus, frontal cerebral cortex, and cerebellum of the guinea pig. Dev Brain Res 92:18-23.
5. Cook MN, Nakatsu K, Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK and Brien JF (1995) Heme oxygenase activity in the adult rat aorta and liver as measured by carbon monoxide formation. Can J Physiol Pharmacol 73:515-518.
6. De Matteis F, Gibbs AH and Harvey C (1985) Studies on the inhibition of ferrochelatase by N-alkylated dicarboxylic porphyrins. Biochem J 224:537-544.
7. Dierks EA, Hu S, Vogel KM, Yu AE, Spiro TG and Burstyn JN (1997) Demonstration of the role of scission of the proximal histidine-iron bond in the activation of soluble guanylyl cyclase through metalloporphyrin substitution studies. J Am Chem Soc 119:7316-7323.
8. Furchgott RF and Jothianandan D (1991) Endothelium-dependent and -independent vasodilation involving cyclic GMP: Relaxation induced by nitric oxide, carbon monoxide and light. Blood Vessels 28:52-61.
9. Gomall AG, Bardawill CJ and David MM (1949) Determination of serum proteins by means of the biuret reaction. J Biol Chem 177:751-766.
10. Grundemar L and Ny L (1997) Pitfalls using metalloporphyrins in carbon monoxide research. Trends Pharmacol Sci 18:193-195.
11. Hussain AS, Marks GS, Brien JF and Nakatsu K (1997) The soluble guanylyl cyclase inhibitor 1H-[1,2,4]oxadiazolo[4,3-α]quinoxalin-l-one (ODQ) inhibits relaxation of rabbit aortic rings induced by carbon monoxide, nitric oxide, and glyceryl trinitrate. Can J Physiol Pharmacol 75:1034-1037.
12. Kimura KA, Parr AM and Brien JF (1996) Effect of chronic maternal ethanol administration of nitric oxide synthase activity in the hippocampus of the mature fetal guinea pig. Alcohol Clin Exp Res 20:948-953.
13. Liu Z, Nakatsu K, Brien JF, Beaton D, Marks GS and Maurice DH (1993) Selective sequestration of nitric oxide by subcellular components of vascular smooth muscle and platelets: Relationship to nitric oxide stimulation of the soluble guanylyl cyclase. Can J Physiol Pharmacol 71:938-945.
14. Luo D and Vincent SR (1994) Metalloporphyrins inhibit nitric oxide-dependent cGMP formation in vivo. Eur J Pharmacol 267:263-267.
15. Marks GS, Brien JF, Nakatsu K and McLaughlin BE (1991) Does carbon monoxide have a physiological function? Trends Pharmacol Sci 12:185-188.
16. Marks GS, McLaughlin BE, Vreman HJ, Stevenson DK, Nakatsu K, Brien JF and Pang SC (1997) Heme oxygenase activity and immunohistochemical localization in bovine pulmonary artery and vein. J Cardiovasc Pharmacol 30:1-6.
17. Meffert MK, Haley JE, Schuman EM, Schulman H and Madison DV (1994) Inhibition of hippocampal heme oxygenase, nitric oxide synthase, and long-term potentiation by metalloporphyrins. Neuron 13:1225-1233,
18. Moncada S, Palmer RMJ and Higgs EA (1991) Nitric oxide: Physiology, pathophysiology, and pharmacology. Pharmacol Rev 43:109-142.
19. Odrcich MJ, Graham CH, Kimura KA, McLaughlin BE, Marks GS, Nakatsu K and Brien JF (1998) Heme oxygenase and nitric oxide synthase in the placenta of the guinea-pig during gestation. Placenta 19:509-516.
20. Qato MK and Maines MD (1985) Prevention of neonatal hyperbilirubinaemia in non-human primates by Zn-protoporphyrin. Biochem J 226:51-57.
21. Serfass L and Burstyn JN (1998) Effect of heme oxygenase inhibitors on soluble guanylyl cyclase activity. Arch Biochem Biophys 359:8-16.
22. Shinomura T, Nako SI and Mori K (1994) Reduction of depolarization-induced glutamate release by heme oxygenase inhibitor: Possible role of carbon monoxide in synaptic transmission. Neurosci Lett 166:131-134.
23. Smith PK, Krohn RI, Hermanson GT, Mallia AK, Gartner FH, Provenzano MD, Fujimoto EK, Goeke NM, Olson BG and Klenk DC (1985) Measurement of protein using bicinchoninic acid. Anal Biochem 150:76-85.
24. Valaes T, Drummond GS and Kappas A (1998) Control of hyperbilirubinemia in glucose-6-phosphate dehydrogenase-deficient newborns using an inhibitor of bilirubin production, Snmesoporphyrin. Pediatrics 101:E11-E17.
25. Valaes T, Pelmezaki S, Henschke C, Drummond GS and Kappas A (1994) Control of jaundice in preterm newborns by an inhibitor of bilirubin production: Studies with tin mesoporphyrin. Pediatrics 93:1-11.
26. Vallier HA, Rodgers PA and Stevenson DK (1991) Oral administration of zinc deuteroporphyrin IX 2,4 bis glycol inhibits heme oxygenase in neonatal rats. Dev Pharmacol Ther 17:109-115.
27. Vallier HA, Rodgers PA and Stevenson DK (1993) Inhibition of heme oxygenase after oral vs intraperitoneal administration of chromium porphyrins. Life Sci 52:L79-84.
28. Vedernikov YP, Gräser T and Vanin AF (1989) Similar endothelium-independent arterial relaxation by carbon monoxide and nitric oxide. Biomed Biochim Acta 8:601-603.
29. Verma A, Hirsch DJ, Glatt CE, Ronnett GV and Snyder SH (1993) Carbon monoxide: A putative neural messenger. Science (Wash DC) 259:381-384.
30. Vreman HJ, Ekstrand BC and Stevenson DK (1993) Selection of metalloporphyrin heme oxygenase inhibitors based on potency and photoreactivity. Pediatr Res 33:195-200.
31. Vreman HJ, Lee OK and Stevenson DK (1992) In vitro and in vivo characteristics of the heme oxygenase inhibitor: ZnMG. Am J Med Sci 302:335-341.
32. Vreman HJ and Stevenson DK (1988) Heme oxygenase activity as measured by carbon monoxide production. Anal Biochem 168:31-38.
33. Vreman HJ, Wong RJ, Williams SA and Stevenson DK (1998) In vitro heme oxygenase isozyme activity inhibition by metalloporphyrins. Pediatr Res 43:202A.
34. Zakhary R, Gaine SP, Dinerman JL, Ruat M, Flavahan NA and Snyder SH (1996) Heme oxygenase 2: Endothelial and neuronal localization and role in endothelium-dependent relaxation. Proc Natl Acad Sci USA 93:795-798.
35. Zakhary R, Poss KD, Jaffrey SR, Ferris CD, Tonegawa S and Snyder SH (1997) Targeted gene deletion of heme oxygenas 2 reveals neural role for carbon monoxide. Proc Natl Acad Sci USA 94:14848-14853.
36. Zhuo M, Small SA, Kandel ER and Hawkins RD (1993) Nitric oxide and carbon monoxide produce activity-dependent long-term synaptic enhancement in hippocampus. Science (Wash DC) 260:1946-1950.